IP Library Assignment 052394/0900
Patent Assignment
Reel/Frame 052394/0900

Assignment of Assignor's Interest

Recorded: 2020-04-14 Pages: 8
Assignors
BENDER, JAMES
Executed: 2017-05-18
WARDELL, SETH
Executed: 2018-01-04
LOTZE, MICHAEL T.
Executed: 2017-05-18
Assignee
LION BIOTECHNOLOGIES, INC.
999 SKYWAY ROAD, SUITE 150, SAN CARLOS, CALIFORNIA, 94070
Covered Properties (6)
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,361 →
Publication: US 2020/0276241
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,386 →
Publication: US 2020/0306306
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,426 →
Publication: US 2020/0306307
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,442 →
Publication: US 2020/0246384
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,454 →
Publication: US 2020/0276242
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,474 →
Publication: US 2020/0281978
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Apr 14, 2020
From: LION BIOTECHNOLOGIES, INC.
To: IOVANCE BIOTHERAPEUTICS, INC.
Reel/Frame 052397/0854 →